These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia. E B, Ko K, Kim R, Nagashima S, Ouoba S, Hussain MRA, Sato T, Chuon C, Abe K, Sugiyama A, Takahashi K, Akita T, Tung R, Ork V, Hossain MS, Saphonn V, Tanaka J. BMC Infect Dis; 2023 Apr 26; 23(1):261. PubMed ID: 37101167 [Abstract] [Full Text] [Related]
6. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province]. Zhang BF, Cheng ML, Zhang Q, Zhao XK, Yu L, Yang J, Deng KS, Zhang LS, Wang J, Hu YX. Zhonghua Gan Zang Bing Za Zhi; 2018 Dec 20; 26(12):945-950. PubMed ID: 30669789 [Abstract] [Full Text] [Related]
7. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission. Zhang L, Gui X, Wang B, Ji H, Yisilafu R, Li F, Zhou Y, Zhang L, Zhang H, Liu X. Eur J Pediatr; 2014 Sep 20; 173(9):1161-8. PubMed ID: 24699981 [Abstract] [Full Text] [Related]
8. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Ding Y, Sheng Q, Ma L, Dou X. Virol J; 2013 Jan 07; 10():17. PubMed ID: 23294983 [Abstract] [Full Text] [Related]
9. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China. Chen T, Wang J, Qiu H, Yu Q, Yan T, Qi C, Cao F, Tian Z, Guo D, Yao N, Yang Y, He Y, Zhao Y, Liu J. Medicine (Baltimore); 2018 Jul 07; 97(27):e11406. PubMed ID: 29979437 [Abstract] [Full Text] [Related]
10. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, Salvadori N, Decker L, Traisathit P, Sirirungsi W, Khamduang W, Bowonwatanuwong C, Puthanakit T, Siberry GK, Watts DH, Murphy TV, Achalapong J, Hongsiriwon S, Klinbuayaem V, Thongsawat S, Chung RT, Pol S, Chotivanich N. BMC Infect Dis; 2016 Aug 09; 16():393. PubMed ID: 27506549 [Abstract] [Full Text] [Related]
11. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX. J Hepatol; 2011 Dec 09; 55(6):1215-21. PubMed ID: 21703206 [Abstract] [Full Text] [Related]
12. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study. Sheng QJ, Wang SJ, Wu YY, Dou XG, Ding Y. Medicine (Baltimore); 2018 Jun 09; 97(22):e10931. PubMed ID: 29851831 [Abstract] [Full Text] [Related]
13. Perinatal transmission in infants of mothers with chronic hepatitis B in California. Burgis JC, Kong D, Salibay C, Zipprich J, Harriman K, So S. World J Gastroenterol; 2017 Jul 21; 23(27):4942-4949. PubMed ID: 28785148 [Abstract] [Full Text] [Related]
14. Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting. Thumbiran NV, Moodley D, Parboosing R, Moodley P. S Afr Med J; 2014 Apr 21; 104(4):307-9. PubMed ID: 25118561 [Abstract] [Full Text] [Related]
15. Perinatal transmission of hepatitis B virus: an Australian experience. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, Maley MW, Ayres A, Locarnini SA, Levy MT. Med J Aust; 2009 May 04; 190(9):489-92. PubMed ID: 19413519 [Abstract] [Full Text] [Related]
16. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting. Duri K, Munjoma PT, Mataramvura H, Mazhandu AJ, Chandiwana P, Marere T, Gumbo FZ, Mazengera LR. BMC Infect Dis; 2023 Oct 27; 23(1):736. PubMed ID: 37891471 [Abstract] [Full Text] [Related]
17. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, Sun J, Hou J. J Med Virol; 2003 Nov 27; 71(3):360-6. PubMed ID: 12966540 [Abstract] [Full Text] [Related]
18. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. Chotun N, Nel E, Cotton MF, Preiser W, Andersson MI. Vaccine; 2015 Aug 26; 33(36):4618-22. PubMed ID: 26163924 [Abstract] [Full Text] [Related]
19. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women. Lu LL, Chen BX, Wang J, Wang D, Ji Y, Yi HG, Chen T, Zhang Y, Petersen E, Li Q, Qu C. Int J Infect Dis; 2014 Nov 26; 28():41-4. PubMed ID: 25245000 [Abstract] [Full Text] [Related]
20. Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-Vaccination Serologic Testing. Su WJ, Chen HL, Chen SF, Liu YL, Wang TA, Ho YC, Chang MH. Clin Infect Dis; 2024 Sep 26; 79(3):690-700. PubMed ID: 38562001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]